CGAS and steatosis: Genetically engineered probiotics like ZB183 have shown potential benefits; in a MASH murine model, Zbiotics downregulated the cGAS-STING pathway, reducing liver inflammation and steatosis and improving colonic health, indicating its potential as a novel therapeutic candidate [101].